BCE Emergis Sells US Health Operations

BCE Emergis Inc. closed, on March 4, 2004, the sale of all the shares of BCE Emergis Corp., which carried on its health business in the US, for US$213 million in cash to MultiPlan, Inc., a healthcare network in the US. The price is subject to certain adjustment clauses.

MultiPlan was represented in the US by William Weaver, Pam Chen, Wade Leathers, Evan Makela, Douglas Newkirk, Joel Schaider and Jeffrey Schumacher of Sachnoff & Weaver in Chicago. General Atlantic Partners, LLC, MultiPlan’s financial partner, was represented by Paul, Weiss, Rifkind, Wharton & Garrison LLP in New York, with a team that included Douglas Cifu, Yvonne Chan, Ji Lu, Dale Sarro, Richard Bronstein, William Lee, John Mercury, Claudine Meredith-Groujon, Michael Levin, Elizabeth Moody, Allison Engel, Victoria Zerjav, Rachel Ettinger, Takeshi Kamon and Elizabeth Stein; and assisted in Canada by John Leopold and France Margaret Bélanger (securities) of Stikeman Elliott LLP.

BCE Emergis’ legal team was led by Monique Mercier, executive vice-president, law, and corporate secretary; and Michèle Bolduc, general counsel, operations; and assisted in Canada by Ogilvy Renault in Montreal, with a team that included Francis Legault, Sara JoliCoeur, Marc Tremblay and Dominique Fortin (mergers and acquisitions, and securities) and Mario Caron (real estate); and in the US by Steven Epstein, Robert Reif and Helen Quick (corporate and health regulatory) of Epstein Becker & Green, PC, in Washington, DC, and Pete Ruegger, Patrick James Naughton and Daniel Lee (corporate), Charles Rappaport and Audra Lazarus (tax), and Joseph Tringali and Kenneth Ehrhard (competition) of Simpson Thacher & Bartlett LLP in New York.